Synthesis and anti-platelet activity of novel arylsulfonate–acylhydrazone derivatives, designed as antithrombotic candidates

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

Michael J. S. Dewar, Eve G. Zoebisch, Eamonn F. Healy et al. · Journal of the American Chemical Society · 1985 · 13.1K citations

Natural Sciences, Chemistry, Physics +10

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Thienkhai Vu, David T. Hung, V I Wheaton et al. · Cell · 1991 · 3K citations

Life Sciences, Biochemistry, Molecular Biology +14

The aggregation of blood platelets

G. V. R. Born, Michael Cross · The Journal of Physiology · 1963 · 2.1K citations

Medicine, Cell Biology, Hematology +12

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

Circulation · 1992 · 544 citations · Full text

Medicine, Cardiology, Pharmacology +17

New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives

Gildásio A. Silva, Luciana M.M. Costa, Fernanda Brito et al. · Bioorganic & Medicinal Chemistry · 2004 · 142 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9